Humacyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	80.45	149.77	217.5	39.93	93.71
Short-Term Investments	0	2.11	8	0	0
Cash & Cash Equivalents	80.45	151.88	225.5	39.93	93.71
Cash Growth	-47.03%	-32.65%	464.76%	-57.39%	-
Receivables	0	0.03	0.18	0.11	0.6
Other Current Assets	2.83	2.3	3.66	1.41	0.64
Total Current Assets	83.28	154.21	229.34	41.45	94.95
Property, Plant & Equipment	44.1	49.41	57.19	65.24	73.74
Other Long-Term Assets	0.84	0.68	0	0	0
Total Long-Term Assets	44.95	50.09	57.19	65.24	73.74
Total Assets	128.22	204.3	286.53	106.69	168.69
Accounts Payable	6.49	1.6	2.09	2.27	3.27
Current Debt	2.61	10.88	2.03	4.22	1.57
Other Current Liabilities	9.34	7.11	6.93	4.74	6
Total Current Liabilities	18.44	19.58	11.05	11.23	10.84
Long-Term Debt	54.89	39.19	49.15	24.64	25.65
Other Long-Term Liabilities	41.34	28.61	104.16	0.14	0
Total Long-Term Liabilities	96.23	67.79	153.31	24.78	25.65
Total Liabilities	114.68	87.37	164.36	36.02	36.49
Total Debt	57.51	50.07	51.18	28.86	27.22
Debt Growth	14.86%	-2.17%	77.33%	6.04%	-
Retained Earnings	-537.31	-426.54	-414.57	-388.1	-321.57
Shareholders' Equity	13.55	116.93	122.17	-350.32	-288.79
Net Cash / Debt	22.94	101.81	174.32	11.07	66.5
Net Cash / Debt Growth	-77.47%	-41.60%	1475.03%	-83.36%	-
Net Cash Per Share	0.22	0.99	4.36	1.92	3.30
Working Capital	64.84	134.63	218.29	30.22	84.11
Book Value Per Share	0.13	1.14	3.06	-60.76	-14.35

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).